THE RESPONSIVENESS OF THE ENDOGENOUS INHIBITOR OF cAMP-DEPENDENT PROTEIN KINASE TO ISOPROTERENOL AFTER PROLONGED TREATMENT WITH NIFEDIPINE

Author： Zalewska-Kaszubska J.   Marczak G.   Wejman I.   Wiktorowska A.  

Publisher： Academic Press

ISSN： 1043-6618

Source： Pharmacological Research, Vol.37, Iss.2, 1998-02, pp. : 151-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The cAMP-Dependent Protein Kinase Pathway as Therapeutic Target - Possibilities and Pitfalls

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 11, 2011-06 ,pp. : 1393-1405

Bentham Science Publishers

Access to resources Recommend Favorite

The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia

By Tardito D.   Maina G.   Tura G.B.   Bogetto F.   Pioli R.   Ravizza L.   Racagni G.   Perez J.  

European Neuropsychopharmacology, Vol. 11, Iss. 3, 2001-06 ,pp. : 221-225

Elsevier

Access to resources Recommend Favorite

Tolerance to morphine at the -opioid receptor differentially induced by cAMP-dependent protein kinase activation and morphine

By Wang Z.   Sadee W.  

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 165-171

Elsevier

Access to resources Recommend Favorite

The protein kinase C-β inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications

By Vinik Aaron  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1547-1559

Informa Healthcare

Access to resources Recommend Favorite

Prolonged AMP-activated protein kinase induction impairs vascular functions

By Ertuna Elif  

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 12, 2013-01 ,pp. : 1025-1030

NRC Research Press

Access to resources Recommend Favorite